home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Potential Therapeutic Target In Down Syndrome

  March, 8 2007 8:24
your information resource in human molecular genetics
Blocking the actions of an inhibitory neurotransmitter can improve performance in several memory tasks in a mouse model of Down syndrome, reports a Brief Communication in Nature Neuroscience.

Down syndrome is the most common form of human mental retardation and is caused by the triplication of chromosome 21. Individuals with Down syndrome often have deficits in their memory for facts and events, called declarative memory. The Down syndrome model mouse, which has an extra copy of a segment of chromosome 16 - homologous to human chromosome 21 - shows some of the features of the human disorder, including deficits in declarative memory. The mutant mice also demonstrate excessive inhibition - mediated by the neurotransmitter GABA - in their brains.

Craig Garner and colleagues report that subtly reducing inhibitory function in these mice can rescue their cognitive deficits. The authors treated Down syndrome mice for two weeks with one of two drugs that inhibit the GABA receptor. Both drugs improved their performance in two declarative memory tasks. Moreover, this improvement lasted for up to two months after the drug treatment was stopped. The authors also found a normalization of long-term potentiation, which is the ability of synapses to undergo long-lasting changes in synaptic strength, considered a correlate of learning and memory. Although these findings need to be validated by clinical studies, they suggest that GABA might represent a potential therapeutic target to improve cognitive impairments in Down syndrome.

Author contact:

Craig Garner (Stanford University, Palo Alto, CA, USA)
E-mail: cgarner@stanford.edu

Abstract available online.

(C) Nature Neuroscience press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.